Globus Medical(NYSE) GMED

Globus Medical, Inc. NYSE:GMED makes tools that help doctors fix bone problems. Its products help patients recover from injuries or long-term pain. The company sells these solutions to hospitals and surgery centers.

Tools for the Operating Room

• Musculoskeletal Solutions: Implantable devices and biologics for spinal and orthopedic procedures; includes spinal cord stimulation for chronic pain.
• Enabling Technologies: Computer systems for robotic surgery and imaging; designed to improve implant placement accuracy.
• Neuromonitoring Services: Software that detects nerves during surgery; used to help surgeons avoid accidental nerve damage.

Strategic Moves and Mergers

• Acquired Nevro Corp on April 3, 2025, to add spinal cord stimulation technology to its portfolio.
• Launched the 2025 Strategic Integration Plan to manage business transitions following the recent merger.
• Expanded international sales reach to approximately 61 countries through a mix of direct and distributor networks.
• Increased the U.S. sales force to strengthen its market position in domestic hospitals.

Why Globus Stands Out

The company uses an engineering-driven approach to quickly turn surgeon feedback into new medical devices. Its systems combine robotic assistance with physical implants to make complex surgeries safer for patients.

Key Figures and Results

• Total net sales reached $789.6 million for the three-month period ended June 30, 2026, up 5.9% year over year.
• International net sales grew to $170.5 million during the second quarter of 2026, an 18.0% increase year over year.
• Net cash provided by operating activities was $412.1 million for the six-month period ended June 30, 2026.
• Selling, general, and administrative expenses fell 5.5% to $286.8 million during the three-month period ended June 30, 2026.

Bottom Line

Globus Medical has transitioned from a spinal implant specialist into a broad musculoskeletal technology provider. The integration of robotics and neuromodulation assets supports its goal of improving surgical outcomes.